A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
May 21, 2019
Primary Completion Date
July 2, 2019
Study Completion Date
July 16, 2019
Conditions
Healthy Volunteer
Interventions
DRUG
gilteritinib
oral
DRUG
gilteritinib mini tablet
oral
Trial Locations (1)
21225
EPCU - Parexel, Baltimore
All Listed Sponsors
lead
Astellas Pharma Global Development, Inc.
INDUSTRY
NCT03964038 - A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects | Biotech Hunter | Biotech Hunter